Your browser doesn't support javascript.
loading
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer.
Konecny, G E; Hendrickson, A E Wahner; Davidson, T M; Winterhoff, B J; Ma, S; Mahner, S; Sehouli, J; Fasching, P A; Feisel-Schwickardi, G; Poelcher, M; Roman, L D; Rody, A; Karlan, B Y; Mullany, S A; Chen, H; Ray-Coquard, I L; Provencher, D M; Yachnin, A; Cottu, P H; Glaspy, J A; Haluska, P; Slamon, D J.
Afiliação
  • Konecny GE; Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, USA; Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: gkonecny@mednet.ucla.edu.
  • Hendrickson AEW; Division of Oncology Mayo Clinic, Rochester, MN, USA.
  • Davidson TM; Division of Oncology Mayo Clinic, Rochester, MN, USA.
  • Winterhoff BJ; Department of Obstetrics and Gynecology, University of Minnesota, Minneapolis, MN, USA.
  • Ma S; Institute for Health Informatics, School of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Mahner S; Department of Gynecology and Gynecologic Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Sehouli J; University Hospital Charite, Campus Virchow-Klinikum, Klinik für Frauenheilkunde und Geburtshilfe & Nord-Ostdeutsche-Gesellschaft für Gynäkologische Onkologie (NOGGO), Berlin, Germany.
  • Fasching PA; Department of Obstetrics and Gynecology, University of Erlangen, Erlangen, Germany.
  • Feisel-Schwickardi G; Gynäkologischen Tumorzentrum, Klinikum Kassel, Kassel, Germany.
  • Poelcher M; Department of Gynecology, Rotkreutzklinikum, Munich, Germany.
  • Roman LD; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Rody A; Department of Obstetrics and Gynecology, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Germany.
  • Karlan BY; Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Mullany SA; Department of Obstetrics and Gynecology, University of Minnesota, Minneapolis, MN, USA.
  • Chen H; Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Ray-Coquard IL; Centre Léon Bérard, Lyon, France.
  • Provencher DM; CHUM - Pavillon Notre-Dame, Montréal, QC, Canada.
  • Yachnin A; Department of Oncology, Kaplan Medical Center, Rehovot, Israel.
  • Cottu PH; Institut Curie, Paris, France.
  • Glaspy JA; Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Haluska P; Bristol-Myers Squibb Inc, Lawrenceville, NJ, USA.
  • Slamon DJ; Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, USA.
Gynecol Oncol ; 163(3): 465-472, 2021 12.
Article em En | MEDLINE | ID: mdl-34642026
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Epitelial do Ovário Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Epitelial do Ovário Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article